LEUPROLIDE

LEUPROLIDE was reported 78181 times

LEUPROLIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VIRILISM FOETAL 4 0.6667
1 ENDOMETRIAL SARCOMA METASTATIC 1 0.2500
2 ANTI-ANDROGEN WITHDRAWAL SYNDROME 3 0.1429
3 HEREDITARY OPTIC ATROPHY 10 0.1429
4 BLOOD ALBUMIN 1 0.0909
5 HERBAL TOXICITY 2 0.0667
6 BRAINSTEM COMPRESSION 2 0.0645
7 VICTIM OF CHILD ABUSE 15 0.0598
8 METASTATIC SALIVARY GLAND CANCER 2 0.0556
9 PITUITARY APOPLEXY 9 0.0511
10 BIOPSY PROSTATE ABNORMAL 1 0.0476
11 BLOOD SODIUM 1 0.0455
12 CHILD ABUSE 11 0.0425
13 ALPHA-1 ANTI-TRYPSIN DECREASED 1 0.0417
14 BLOOD GONADOTROPHIN INCREASED 1 0.0400
15 FREE PROSTATE-SPECIFIC ANTIGEN INCREASED 1 0.0357
16 EPIDURAL LIPOMATOSIS 12 0.0349
17 APPARENT MINERALOCORTICOID EXCESS 2 0.0345
18 ANTIANDROGEN THERAPY 1 0.0278
19 VIRILISM 3 0.0273
20 GASTROENTERITIS SHIGELLA 1 0.0270
21 ADENOCARCINOMA OF SALIVARY GLAND 1 0.0256
22 PERIPORTAL OEDEMA 3 0.0240
23 HYPERURICOSURIA 1 0.0227
24 BLOOD POTASSIUM 1 0.0222
25 TESTICULAR FAILURE 3 0.0219
26 END-TIDAL CO2 DECREASED 1 0.0213
27 POCKET EROSION 2 0.0180
28 INJECTION SITE ABSCESS STERILE 2 0.0177
29 HAEMATOCRIT 1 0.0175
30 ECTOPIC ACTH SYNDROME 1 0.0169
31 PRODUCT DOSAGE FORM ISSUE 8 0.0166
32 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 1 0.0161
33 CYSTATIN C INCREASED 2 0.0156
34 BLOOD BILIRUBIN 1 0.0149
35 HORMONE-DEPENDENT PROSTATE CANCER 1 0.0143
36 GLOMERULAR FILTRATION RATE 1 0.0137
37 TRANSIENT ACANTHOLYTIC DERMATOSIS 4 0.0136
38 ERYTHROLEUKAEMIA 1 0.0132
39 ADNEXAL TORSION 4 0.0126
40 BLOOD CHLORIDE ABNORMAL 2 0.0123
41 BLADDER STENOSIS 1 0.0122
42 EPIPHYSIOLYSIS 3 0.0120
43 HEMIANOPIA HETERONYMOUS 1 0.0116
44 EYE ABSCESS 3 0.0098
45 OPTIC DISC DISORDER 2 0.0095
46 HORMONE-REFRACTORY PROSTATE CANCER 11 0.0093
47 PRODUCT CONTAMINATION CHEMICAL 2 0.0092
48 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 3 0.0090
49 COMPLICATED APPENDICITIS 1 0.0085
50 HYPERPHOSPHATURIA 1 0.0085
51 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 3 0.0084
52 OVARIAN HYPERSTIMULATION SYNDROME 19 0.0081
53 VASCULAR GRAFT OCCLUSION 3 0.0078
54 BETA 2 MICROGLOBULIN INCREASED 2 0.0077
55 MILK-ALKALI SYNDROME 4 0.0076
56 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL 1 0.0075
57 DECOMPENSATED HYPOTHYROIDISM 1 0.0074
58 CALCIUM IONISED INCREASED 1 0.0072
59 ALKALOSIS HYPOCHLORAEMIC 1 0.0071
60 HEPATOPULMONARY SYNDROME 1 0.0070
61 ENGRAFT FAILURE 2 0.0070
62 BLOOD CREATININE 1 0.0065
63 AMINOACIDURIA 1 0.0063
64 TUMOUR MARKER ABNORMAL 2 0.0060
65 HEPATOJUGULAR REFLUX 1 0.0060
66 NEUROENDOCRINE CARCINOMA 4 0.0058
67 BLOOD LUTEINISING HORMONE DECREASED 1 0.0056
68 GAMMOPATHY 1 0.0055
69 BLOOD ALKALINE PHOSPHATASE 1 0.0054
70 B-LYMPHOCYTE COUNT INCREASED 1 0.0054
71 HERPES SIMPLEX OESOPHAGITIS 1 0.0054
72 CYSTITIS RADIATION 1 0.0052
73 HAEMOGLOBIN 1 0.0050
74 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
75 IIIRD NERVE PARALYSIS 4 0.0049
76 JUVENILE IDIOPATHIC ARTHRITIS 12 0.0049
77 PROSTATE CANCER RECURRENT 3 0.0049
78 ADENOCARCINOMA METASTATIC 1 0.0049
79 PROSTATE CANCER METASTATIC 16 0.0048
80 BLOOD TESTOSTERONE ABNORMAL 5 0.0045
81 ALANINE AMINOTRANSFERASE 1 0.0045
82 PLEURAL THICKENING 3 0.0044
83 VASOGENIC CEREBRAL OEDEMA 3 0.0042
84 ASPARTATE AMINOTRANSFERASE 1 0.0041
85 FOREIGN BODY REACTION 1 0.0041
86 ANORECTAL INFECTION 1 0.0040
87 CHOLANGITIS SCLEROSING 8 0.0039
88 GINGIVAL EROSION 1 0.0039
89 DENTURE WEARER 1 0.0039
90 GASTROENTERITIS NOROVIRUS 5 0.0038
91 GALLBLADDER OBSTRUCTION 1 0.0038
92 HAEMORRHAGIC INFARCTION 2 0.0036
93 THYROTOXIC CRISIS 4 0.0035
94 HYPOURICAEMIA 1 0.0034
95 ALOPECIA UNIVERSALIS 1 0.0034
96 HILAR LYMPHADENOPATHY 3 0.0034
97 BLOOD OESTROGEN INCREASED 2 0.0034
98 HYPERTENSIVE EMERGENCY 4 0.0034
99 BREAST ENGORGEMENT 1 0.0034
100 ALVEOLAR PROTEINOSIS 2 0.0034
101 ENTEROBACTER BACTERAEMIA 1 0.0033
102 OPEN ANGLE GLAUCOMA 2 0.0033
103 APLASTIC ANAEMIA 17 0.0033
104 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
105 BLOOD UREA ABNORMAL 3 0.0032
106 ARNOLD-CHIARI MALFORMATION 3 0.0031
107 IMMUNOGLOBULIN G4 RELATED DISEASE 1 0.0031
108 COLORECTAL ADENOMA 1 0.0031
109 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
110 ALOPECIA TOTALIS 1 0.0030
111 SARS-COV-2 TEST NEGATIVE 2 0.0030
112 POSITRON EMISSION TOMOGRAM ABNORMAL 2 0.0029
113 OPHTHALMIC HERPES ZOSTER 5 0.0028
114 FOREIGN BODY IN GASTROINTESTINAL TRACT 1 0.0027
115 BODY DYSMORPHIC DISORDER 1 0.0027
116 BLADDER PERFORATION 1 0.0026
117 HYPOGLYCAEMIC ENCEPHALOPATHY 1 0.0026
118 CRITICAL ILLNESS 2 0.0026
119 ENDOMETRIAL DISORDER 1 0.0024
120 CANDIDA TEST POSITIVE 1 0.0024
121 CARBON MONOXIDE POISONING 1 0.0023
122 CUTANEOUS SARCOIDOSIS 1 0.0023
123 ALOPECIA AREATA 4 0.0023
124 CLOSTRIDIUM TEST POSITIVE 5 0.0023
125 BLADDER HYPERTROPHY 1 0.0023
126 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
127 INVASIVE DUCTAL BREAST CARCINOMA 6 0.0022
128 GALLBLADDER RUPTURE 1 0.0022
129 CEREBRAL HYPOPERFUSION 1 0.0021
130 SCROTAL SWELLING 2 0.0021
131 BLOOD BICARBONATE INCREASED 1 0.0021
132 AMNESTIC DISORDER 1 0.0021
133 BLADDER MASS 1 0.0020
134 TESTICULAR DISORDER 2 0.0020
135 BLADDER OBSTRUCTION 1 0.0019
136 BREAST NEOPLASM 2 0.0019
137 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 2 0.0019
138 PROSTATIC SPECIFIC ANTIGEN INCREASED 26 0.0019
139 RADIATION INJURY 2 0.0019
140 BODY FAT DISORDER 1 0.0018
141 INTERTRIGO 1 0.0018
142 BLOOD PH INCREASED 1 0.0018
143 IMMUNE-MEDIATED HYPOTHYROIDISM 2 0.0018
144 CORTISOL DECREASED 2 0.0017
145 HAEMORRHAGIC OVARIAN CYST 1 0.0017
146 ENTERAL NUTRITION 1 0.0017
147 HYPOPITUITARISM 3 0.0017
148 ENGRAFTMENT SYNDROME 1 0.0017
149 FAT NECROSIS 1 0.0016
150 METASTASES TO BONE 27 0.0016
151 HAEMATOCRIT ABNORMAL 2 0.0016
152 INTRADUCTAL PROLIFERATIVE BREAST LESION 2 0.0016
153 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
154 BLOOD BILIRUBIN ABNORMAL 2 0.0016
155 METASTASES TO SPINE 5 0.0015
156 BODY MASS INDEX INCREASED 2 0.0015
157 CYST RUPTURE 1 0.0015
158 FLUID IMBALANCE 1 0.0014
159 BLOOD TESTOSTERONE INCREASED 3 0.0014
160 RESPIRATORY DEPRESSION 17 0.0014
161 BACTERIAL DISEASE CARRIER 1 0.0014
162 ESCHAR 1 0.0014
163 HEMIANOPIA HOMONYMOUS 1 0.0014
164 DIFFERENTIATION SYNDROME 1 0.0014
165 DRUG-DISEASE INTERACTION 1 0.0014
166 IDIOPATHIC INTRACRANIAL HYPERTENSION 3 0.0013
167 TROPONIN INCREASED 10 0.0013
168 BREAST CANCER METASTATIC 14 0.0013
169 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
170 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
171 METASTASIS 9 0.0013
172 EMBOLIA CUTIS MEDICAMENTOSA 1 0.0013
173 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
174 METABOLIC ALKALOSIS 2 0.0012
175 PITUITARY TUMOUR BENIGN 2 0.0012
176 CAMPYLOBACTER INFECTION 1 0.0012
177 ENTEROBACTER INFECTION 2 0.0012
178 METASTASES TO LYMPH NODES 8 0.0012
179 CRANIOFACIAL FRACTURE 1 0.0012
180 CORONARY ARTERY DISSECTION 1 0.0012
181 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
182 ENTEROCUTANEOUS FISTULA 1 0.0011
183 TERMINAL INSOMNIA 2 0.0011
184 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
185 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
186 ADVERSE FOOD REACTION 1 0.0011
187 HYPOPROTEINAEMIA 2 0.0011
188 CEREBELLAR ATAXIA 1 0.0010
189 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
190 BLOOD TESTOSTERONE DECREASED 7 0.0010
191 TORSADE DE POINTES 8 0.0010
192 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
193 ACQUIRED HAEMOPHILIA 1 0.0010
194 BONE MARROW DISORDER 3 0.0010
195 HYPOGONADISM 1 0.0010
196 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
197 OSTEOLYSIS 2 0.0010
198 BREAST DISCOMFORT 1 0.0010
199 ATRIAL THROMBOSIS 2 0.0010
200 CHEST INJURY 2 0.0010
201 SKIN INDURATION 2 0.0010
202 INSULIN RESISTANCE 2 0.0010
203 COGWHEEL RIGIDITY 1 0.0010
204 NON-CARDIAC CHEST PAIN 3 0.0009
205 OPTIC NEUROPATHY 2 0.0009
206 RENAL NEOPLASM 2 0.0009
207 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
208 HYDRONEPHROSIS 7 0.0009
209 AORTIC DILATATION 1 0.0009
210 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
211 DEMENTIA WITH LEWY BODIES 1 0.0009
212 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
213 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1 0.0009
214 ARTERIAL HAEMORRHAGE 1 0.0009
215 METASTATIC MALIGNANT MELANOMA 2 0.0009
216 HYPOMAGNESAEMIA 12 0.0009
217 CAROTID ARTERY STENOSIS 3 0.0009
218 ALLODYNIA 1 0.0009
219 FEBRILE INFECTION 1 0.0008
220 URINARY TRACT OBSTRUCTION 2 0.0008
221 TRANSPLANT 2 0.0008
222 LONG QT SYNDROME 2 0.0008
223 BONE LESION 3 0.0008
224 PANNICULITIS 2 0.0008
225 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
226 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
227 BLADDER DISCOMFORT 1 0.0008
228 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
229 PLATELET DISORDER 2 0.0008
230 ADENOCARCINOMA PANCREAS 1 0.0008
231 TENDERNESS 8 0.0008
232 TRANSFUSION 8 0.0008
233 ACQUIRED GENE MUTATION 1 0.0008
234 OBESITY 12 0.0008
235 GLYCOSURIA 1 0.0007
236 METASTASES TO LIVER 13 0.0007
237 CALCULUS BLADDER 1 0.0007
238 EFFUSION 1 0.0007
239 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
240 FEBRILE NEUTROPENIA 48 0.0007
241 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
242 FIBULA FRACTURE 2 0.0007
243 TUMOUR LYSIS SYNDROME 6 0.0007
244 GROWTH RETARDATION 2 0.0007
245 CONJUNCTIVITIS ALLERGIC 1 0.0007
246 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
247 PRODUCT PRESCRIBING ERROR 16 0.0007
248 METABOLIC ENCEPHALOPATHY 2 0.0007
249 THYROIDITIS 2 0.0007
250 ACUTE HEPATIC FAILURE 9 0.0007
251 DIASTOLIC DYSFUNCTION 2 0.0006
252 INFERTILITY FEMALE 1 0.0006
253 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
254 INJECTION SITE HYPERSENSITIVITY 2 0.0006
255 ENDOMETRIOSIS 3 0.0006
256 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
257 BREAST ENLARGEMENT 2 0.0006
258 INJECTION SITE INFECTION 2 0.0006
259 INJECTION RELATED REACTION 1 0.0006
260 MALIGNANT NEOPLASM PROGRESSION 62 0.0006
261 ORGANISING PNEUMONIA 3 0.0006
262 ILLUSION 1 0.0006
263 ABDOMINAL TENDERNESS 3 0.0006
264 BLOOD CALCIUM ABNORMAL 1 0.0006
265 CEREBELLAR INFARCTION 1 0.0006
266 PATHOLOGICAL FRACTURE 3 0.0006
267 GLIOBLASTOMA 1 0.0006
268 HOT FLUSH 44 0.0006
269 CEREBRAL ISCHAEMIA 3 0.0006
270 PRIAPISM 2 0.0006
271 THERAPY PARTIAL RESPONDER 9 0.0006
272 FANCONI SYNDROME ACQUIRED 1 0.0006
273 AORTIC VALVE STENOSIS 1 0.0006
274 ANAL INCONTINENCE 5 0.0006
275 CUTANEOUS VASCULITIS 2 0.0005
276 GINGIVAL RECESSION 1 0.0005
277 METASTASES TO LUNG 6 0.0005
278 PRODUCT STORAGE ERROR 45 0.0005
279 CONCOMITANT DISEASE PROGRESSION 1 0.0005
280 URINE ODOUR ABNORMAL 3 0.0005
281 HYPERAEMIA 1 0.0005
282 PNEUMONIA FUNGAL 2 0.0005
283 OESOPHAGEAL PAIN 2 0.0005
284 PATENT DUCTUS ARTERIOSUS 2 0.0005
285 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
286 ENDOPHTHALMITIS 3 0.0005
287 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
288 CARDIAC DISCOMFORT 1 0.0005
289 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
290 IMMUNE-MEDIATED HEPATITIS 1 0.0005
291 POLYURIA 4 0.0005
292 SPINAL STENOSIS 2 0.0005
293 HYPERBILIRUBINAEMIA 5 0.0005
294 DISEASE PROGRESSION 57 0.0005
295 SECOND PRIMARY MALIGNANCY 4 0.0005
296 COAGULOPATHY 8 0.0005
297 DEVICE CONNECTION ISSUE 1 0.0005
298 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
299 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
300 HAEMOGLOBIN ABNORMAL 3 0.0005
301 ABSCESS INTESTINAL 1 0.0005
302 BONE CANCER 2 0.0005
303 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
304 FAECES PALE 1 0.0004
305 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
306 BRAIN FOG 7 0.0004
307 ADENOCARCINOMA 1 0.0004
308 SKIN INFECTION 5 0.0004
309 NEPHROPATHY TOXIC 5 0.0004
310 BLOOD LOSS ANAEMIA 1 0.0004
311 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
312 MYOCARDIAL ISCHAEMIA 5 0.0004
313 BREAKTHROUGH PAIN 1 0.0004
314 RHABDOMYOLYSIS 18 0.0004
315 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
316 HYPERTRANSAMINASAEMIA 3 0.0004
317 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
318 FEELING OF DESPAIR 2 0.0004
319 ERECTILE DYSFUNCTION 11 0.0004
320 BILIRUBIN CONJUGATED INCREASED 1 0.0004
321 DISCOURAGEMENT 1 0.0004
322 EOSINOPHIL COUNT DECREASED 1 0.0004
323 TREATMENT FAILURE 34 0.0004
324 HYPOPHOSPHATAEMIA 3 0.0004
325 HYPERCALCAEMIA 5 0.0004
326 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
327 OSTEONECROSIS OF JAW 10 0.0004
328 PULMONARY MASS 6 0.0004
329 INJECTION SITE ABSCESS 1 0.0004
330 GASTROINTESTINAL TUBE INSERTION 1 0.0004
331 HOSTILITY 1 0.0004
332 HAEMORRHAGE URINARY TRACT 1 0.0004
333 HEPATIC CYTOLYSIS 5 0.0004
334 INCREASED BRONCHIAL SECRETION 1 0.0004
335 HEPATOSPLENOMEGALY 1 0.0004
336 AORTIC ARTERIOSCLEROSIS 1 0.0004
337 BLOOD CHLORIDE DECREASED 1 0.0004
338 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
339 FOOD POISONING 2 0.0004
340 QUALITY OF LIFE DECREASED 5 0.0004
341 OVERWEIGHT 2 0.0004
342 BREAST SWELLING 1 0.0004
343 INJECTION SITE DISCHARGE 2 0.0004
344 BLOOD SODIUM INCREASED 1 0.0004
345 HYPOCALCAEMIA 7 0.0004
346 HYPOKALAEMIA 17 0.0004
347 HYDROCEPHALUS 2 0.0004
348 EOSINOPHILIC OESOPHAGITIS 1 0.0004
349 ATRIAL SEPTAL DEFECT 3 0.0004
350 ACUTE PULMONARY OEDEMA 2 0.0004
351 DRUG TOLERANCE DECREASED 1 0.0004
352 ATYPICAL FEMUR FRACTURE 1 0.0004
353 MITRAL VALVE INCOMPETENCE 4 0.0004
354 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
355 PSEUDOMONAS INFECTION 3 0.0003
356 ABORTION SPONTANEOUS 14 0.0003
357 VENTRICULAR SEPTAL DEFECT 2 0.0003
358 CYTOKINE RELEASE SYNDROME 7 0.0003
359 EXERCISE TOLERANCE DECREASED 2 0.0003
360 MADAROSIS 4 0.0003
361 GASTROINTESTINAL NECROSIS 1 0.0003
362 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
363 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
364 PULMONARY EMBOLISM 32 0.0003
365 BLOOD CULTURE POSITIVE 1 0.0003
366 PLEURAL EFFUSION 20 0.0003
367 DYSAESTHESIA 1 0.0003
368 UROSEPSIS 3 0.0003
369 INJECTION SITE MASS 12 0.0003
370 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
371 ACUTE MYELOID LEUKAEMIA 5 0.0003
372 FOREIGN BODY IN THROAT 1 0.0003
373 BLADDER PAIN 1 0.0003
374 HEPATOTOXICITY 7 0.0003
375 ACUTE RESPIRATORY FAILURE 6 0.0003
376 THERAPY NON-RESPONDER 14 0.0003
377 DRUG RESISTANCE 8 0.0003
378 HEPATITIS ACUTE 2 0.0003
379 BACTERIAL SEPSIS 1 0.0003
380 HEPATIC NEOPLASM 1 0.0003
381 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
382 MUCOSAL INFLAMMATION 8 0.0003
383 HYPERGLYCAEMIA 11 0.0003
384 LEUKOPENIA 15 0.0003
385 COLITIS ISCHAEMIC 2 0.0003
386 POSTOPERATIVE WOUND INFECTION 2 0.0003
387 EYELID PTOSIS 3 0.0003
388 HEPATIC CYST 1 0.0003
389 DEEP VEIN THROMBOSIS 19 0.0003
390 RIB FRACTURE 6 0.0003
391 LYMPHOEDEMA 2 0.0003
392 AORTIC STENOSIS 1 0.0003
393 PANCYTOPENIA 16 0.0003
394 EOSINOPHILIA 5 0.0003
395 INJECTION SITE URTICARIA 7 0.0003
396 HANGOVER 1 0.0003
397 BRONCHIOLITIS 1 0.0003
398 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
399 METABOLIC ACIDOSIS 9 0.0003
400 PRODUCT SUPPLY ISSUE 2 0.0003
401 VISUAL FIELD DEFECT 2 0.0003
402 PELVIC PAIN 5 0.0003
403 NEEDLE ISSUE 8 0.0003
404 CAROTID ARTERY OCCLUSION 1 0.0003
405 WOUND INFECTION 3 0.0003
406 UTERINE LEIOMYOMA 2 0.0003
407 INJECTION SITE NODULE 3 0.0003
408 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
409 CEREBRAL DISORDER 2 0.0003
410 BACTERIAL INFECTION 5 0.0003
411 MIDDLE INSOMNIA 5 0.0003
412 HAEMATURIA 9 0.0003
413 CLAVICLE FRACTURE 1 0.0003
414 LIPASE INCREASED 2 0.0003
415 GINGIVAL DISORDER 1 0.0003
416 NEOPLASM PROGRESSION 9 0.0003
417 MUSCULOSKELETAL CHEST PAIN 4 0.0003
418 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
419 PNEUMONITIS 7 0.0003
420 HAEMORRHAGIC STROKE 2 0.0003
421 EPIGASTRIC DISCOMFORT 1 0.0003
422 PRODUCT USE COMPLAINT 4 0.0003
423 BLOOD ALBUMIN DECREASED 2 0.0003
424 RENAL CYST 2 0.0003
425 PREMATURE DELIVERY 4 0.0003
426 HYPERLIPIDAEMIA 3 0.0003
427 CEREBRAL ATROPHY 1 0.0003
428 ABSCESS 4 0.0003
429 SENSORY LOSS 2 0.0002
430 ACUTE KIDNEY INJURY 38 0.0002
431 GALLBLADDER OPERATION 1 0.0002
432 SHOCK HAEMORRHAGIC 2 0.0002
433 DECUBITUS ULCER 2 0.0002
434 ENCEPHALOPATHY 6 0.0002
435 CARDIOMEGALY 3 0.0002
436 HAIR DISORDER 2 0.0002
437 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
438 SPINAL COMPRESSION FRACTURE 2 0.0002
439 ILEUS 3 0.0002
440 HAIR COLOUR CHANGES 3 0.0002
441 BREAST CANCER STAGE II 2 0.0002
442 BONE PAIN 14 0.0002
443 BLOOD UREA INCREASED 4 0.0002
444 ASCITES 7 0.0002
445 MUSCLE ATROPHY 3 0.0002
446 BUNDLE BRANCH BLOCK LEFT 1 0.0002
447 INJECTION SITE IRRITATION 3 0.0002
448 AORTIC VALVE INCOMPETENCE 1 0.0002
449 PYELONEPHRITIS 2 0.0002
450 INJECTION SITE RASH 7 0.0002
451 BLOOD CALCIUM INCREASED 2 0.0002
452 GRIP STRENGTH DECREASED 2 0.0002
453 LUNG INFILTRATION 2 0.0002
454 GINGIVAL SWELLING 1 0.0002
455 TRANSAMINASES INCREASED 5 0.0002
456 HAIR TEXTURE ABNORMAL 3 0.0002
457 THROMBOCYTOPENIA 25 0.0002
458 DRUG-INDUCED LIVER INJURY 7 0.0002
459 JAUNDICE 6 0.0002
460 LOSS OF LIBIDO 2 0.0002
461 HYPOTHYROIDISM 7 0.0002
462 PNEUMONIA BACTERIAL 2 0.0002
463 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
464 OVARIAN CANCER 2 0.0002
465 HEPATIC ENCEPHALOPATHY 2 0.0002
466 FLANK PAIN 2 0.0002
467 LEUKAEMIA 2 0.0002
468 PROSTATE CANCER 17 0.0002
469 FRACTURE 4 0.0002
470 ABDOMINAL DISTENSION 22 0.0002
471 SUBDURAL HAEMATOMA 3 0.0002
472 DIABETIC KETOACIDOSIS 5 0.0002
473 FAECAL INCONTINENCE 1 0.0002
474 HUMERUS FRACTURE 1 0.0002
475 HYPERTHYROIDISM 3 0.0002
476 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
477 ATELECTASIS 2 0.0002
478 GUILLAIN-BARRE SYNDROME 1 0.0002
479 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
480 INTENTIONAL PRODUCT MISUSE 18 0.0002
481 THROMBOTIC MICROANGIOPATHY 2 0.0002
482 INCORRECT DOSAGE ADMINISTERED 1 0.0002
483 ANAEMIA 39 0.0002
484 COELIAC DISEASE 2 0.0002
485 THERAPY CHANGE 2 0.0002
486 CARDIOMYOPATHY 3 0.0002
487 HYPERVOLAEMIA 1 0.0002
488 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
489 POOR QUALITY DEVICE USED 2 0.0002
490 ERYSIPELAS 1 0.0002
491 CORONARY ARTERY STENOSIS 1 0.0002
492 CORONARY ARTERIAL STENT INSERTION 1 0.0002
493 SUBARACHNOID HAEMORRHAGE 2 0.0002
494 SLUGGISHNESS 2 0.0002
495 BODY TEMPERATURE INCREASED 4 0.0002
496 HYPONATRAEMIA 11 0.0002
497 ATRIAL FIBRILLATION 19 0.0002
498 FEMORAL NECK FRACTURE 1 0.0002
499 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
500 PERITONITIS 4 0.0002
501 EJECTION FRACTION DECREASED 3 0.0002
502 FAILURE TO THRIVE 1 0.0002
503 RESPIRATORY FAILURE 14 0.0002
504 INCONTINENCE 2 0.0002
505 COMPRESSION FRACTURE 1 0.0002
506 LIVER FUNCTION TEST INCREASED 4 0.0002
507 INTERSTITIAL LUNG DISEASE 9 0.0002
508 BLOOD BILIRUBIN INCREASED 5 0.0002
509 COLITIS 7 0.0002
510 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
511 CHOKING SENSATION 1 0.0002
512 DENTAL CARIES 2 0.0002
513 HYPERTENSIVE CRISIS 2 0.0002
514 GAIT INABILITY 6 0.0002
515 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
516 INJECTION SITE PRURITUS 12 0.0002
517 MALNUTRITION 2 0.0002
518 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
519 DRUG INTERACTION 28 0.0002
520 RED BLOOD CELL COUNT DECREASED 5 0.0002
521 NEOPLASM 2 0.0002
522 NEUTROPHIL COUNT DECREASED 7 0.0002
523 HYPOVOLAEMIA 1 0.0002
524 LYMPHOCYTE COUNT DECREASED 3 0.0002
525 ACUTE MYOCARDIAL INFARCTION 5 0.0002
526 LYMPHADENOPATHY 6 0.0002
527 NEUTROPENIA 23 0.0002
528 ATAXIA 2 0.0002
529 NEUROPATHY PERIPHERAL 16 0.0002
530 DRUG ABUSE 14 0.0002
531 DISEASE RECURRENCE 8 0.0002
532 ISCHAEMIC STROKE 3 0.0002
533 CHOLECYSTITIS 2 0.0002
534 INFUSION RELATED REACTION 11 0.0002
535 OSTEOMYELITIS 3 0.0002
536 BLOOD PRESSURE DECREASED 11 0.0002
537 PRODUCT USE IN UNAPPROVED INDICATION 41 0.0002
538 NOCTURIA 2 0.0002
539 PRESYNCOPE 4 0.0002
540 INGUINAL HERNIA 1 0.0002
541 CYTOPENIA 2 0.0002
542 DYSURIA 6 0.0002
543 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
544 SMALL INTESTINAL OBSTRUCTION 2 0.0002
545 INJECTION SITE EXTRAVASATION 2 0.0002
546 TENDON RUPTURE 2 0.0002
547 GENERALISED OEDEMA 2 0.0002
548 CYST 2 0.0002
549 INFUSION SITE EXTRAVASATION 1 0.0002
550 HYPERTENSION 34 0.0002
551 PNEUMONIA ASPIRATION 4 0.0002
552 SECRETION DISCHARGE 2 0.0002
553 HEAD INJURY 5 0.0002
554 TACHYCARDIA 14 0.0002
555 ENTERITIS 1 0.0002
556 CHOLESTASIS 3 0.0002
557 GALACTORRHOEA 1 0.0002
558 NIGHT SWEATS 5 0.0002
559 INJECTION SITE INDURATION 2 0.0002
560 NODULE 2 0.0002
561 KIDNEY INFECTION 3 0.0002
562 HYPOGAMMAGLOBULINAEMIA 1 0.0002
563 GASTRITIS 4 0.0002
564 HAEMATOCRIT DECREASED 3 0.0002
565 CARDIAC FAILURE ACUTE 1 0.0001
566 PREGNANCY 3 0.0001
567 SPINAL FRACTURE 3 0.0001
568 BREAST MASS 1 0.0001
569 OEDEMA 8 0.0001
570 PRODUCT QUALITY ISSUE 20 0.0001
571 MOOD ALTERED 4 0.0001
572 INFARCTION 1 0.0001
573 INJECTION SITE REACTION 10 0.0001
574 ENCEPHALITIS 1 0.0001
575 MENTAL STATUS CHANGES 4 0.0001
576 PULMONARY HYPERTENSION 3 0.0001
577 MASS 2 0.0001
578 DEVICE OCCLUSION 2 0.0001
579 LYMPHOPENIA 2 0.0001
580 SINUS TACHYCARDIA 2 0.0001
581 MYELODYSPLASTIC SYNDROME 2 0.0001
582 SEPTIC SHOCK 6 0.0001
583 BLOOD CREATININE INCREASED 9 0.0001
584 HYPOKINESIA 2 0.0001
585 PRODUCT DISPENSING ERROR 3 0.0001
586 CRYING 5 0.0001
587 APATHY 2 0.0001
588 GASTROENTERITIS 2 0.0001
589 INFLAMMATION 7 0.0001
590 LABORATORY TEST ABNORMAL 4 0.0001
591 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
592 URINARY INCONTINENCE 4 0.0001
593 RASH MACULO-PAPULAR 3 0.0001
594 HAEMORRHAGE INTRACRANIAL 2 0.0001
595 DECREASED APPETITE 31 0.0001
596 BREAST TENDERNESS 1 0.0001
597 HEPATIC FAILURE 4 0.0001
598 CORONARY ARTERY DISEASE 4 0.0001
599 AORTIC ANEURYSM 1 0.0001
600 ACIDOSIS 1 0.0001
601 BOWEL MOVEMENT IRREGULARITY 1 0.0001
602 SHOCK 3 0.0001
603 HYPOTENSION 26 0.0001
604 GYNAECOMASTIA 4 0.0001
605 CONCUSSION 1 0.0001
606 INJECTION SITE ERYTHEMA 16 0.0001
607 DELUSION 2 0.0001
608 EXPOSURE DURING PREGNANCY 8 0.0001
609 HYPOALBUMINAEMIA 1 0.0001
610 CONSTIPATION 28 0.0001
611 MENINGIOMA 2 0.0001
612 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
613 AFFECTIVE DISORDER 1 0.0001
614 FATIGUE 99 0.0001
615 OXYGEN SATURATION DECREASED 7 0.0001
616 MUSCLE TIGHTNESS 2 0.0001
617 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
618 HICCUPS 1 0.0001
619 MULTIPLE FRACTURES 2 0.0001
620 HYPERAESTHESIA 1 0.0001
621 ESCHERICHIA INFECTION 1 0.0001
622 STAPHYLOCOCCAL INFECTION 4 0.0001
623 EMBOLISM 1 0.0001
624 AGEUSIA 3 0.0001
625 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
626 URINARY RETENTION 4 0.0001
627 CARDIO-RESPIRATORY ARREST 5 0.0001
628 HAEMODIALYSIS 1 0.0001
629 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
630 ABDOMINAL PAIN LOWER 3 0.0001
631 CANDIDA INFECTION 2 0.0001
632 HEMIPARESIS 2 0.0001
633 INADEQUATE ANALGESIA 1 0.0001
634 CONFUSIONAL STATE 19 0.0001
635 HYPOPHAGIA 3 0.0001
636 FACIAL PARALYSIS 1 0.0001
637 HEPATITIS 3 0.0001
638 PRODUCT USE ISSUE 22 0.0001
639 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
640 HYPERHIDROSIS 15 0.0001
641 ANURIA 1 0.0001
642 SKIN ULCER 3 0.0001
643 EXPOSURE VIA SKIN CONTACT 3 0.0001
644 CARDIAC MURMUR 1 0.0001
645 VAGINAL HAEMORRHAGE 5 0.0001
646 ORTHOSTATIC HYPOTENSION 2 0.0001
647 LOCAL SWELLING 2 0.0001
648 SYRINGE ISSUE 2 0.0001
649 HYPOXIA 4 0.0001
650 IMMUNOSUPPRESSION 1 0.0001
651 DRUG ERUPTION 2 0.0001
652 CARDIOTOXICITY 1 0.0001
653 DRUG DEPENDENCE 18 0.0001
654 THIRST 2 0.0001
655 PULMONARY OEDEMA 5 0.0001
656 GASTROINTESTINAL INFECTION 1 0.0001
657 DRY MOUTH 9 0.0001
658 RASH PRURITIC 6 0.0001
659 HEADACHE 69 0.0001
660 SYNCOPE 11 0.0001
661 END STAGE RENAL DISEASE 2 0.0001
662 UNDERDOSE 8 0.0001
663 EXOSTOSIS 1 0.0001
664 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
665 ABNORMAL DREAMS 3 0.0001
666 PAIN IN EXTREMITY 32 0.0001
667 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
668 ABDOMINAL PAIN 25 0.0001
669 HEPATIC STEATOSIS 2 0.0001
670 THINKING ABNORMAL 2 0.0001
671 ERYTHEMA MULTIFORME 1 0.0001
672 APPENDICITIS 1 0.0001
673 DEFORMITY 1 0.0001
674 DIARRHOEA HAEMORRHAGIC 1 0.0001
675 OEDEMA PERIPHERAL 13 0.0001
676 HEPATIC CIRRHOSIS 2 0.0001
677 HAEMATOTOXICITY 1 0.0001
678 GASTRIC ULCER 2 0.0001
679 SLEEP APNOEA SYNDROME 2 0.0001
680 MIGRAINE 10 0.0001
681 INCREASED APPETITE 2 0.0001
682 VOMITING 49 0.0001
683 PLATELET COUNT DECREASED 11 0.0001
684 DIZZINESS POSTURAL 1 0.0001
685 HYPOGLYCAEMIA 5 0.0001
686 OFF LABEL USE 90 0.0001
687 DYSSTASIA 3 0.0001
688 HEPATIC ENZYME INCREASED 7 0.0001
689 HEPATOMEGALY 1 0.0001
690 BODY TEMPERATURE DECREASED 1 0.0001
691 HOSPICE CARE 1 0.0001
692 BLADDER DISORDER 1 0.0001
693 NAUSEA 79 0.0001
694 PREMATURE BABY 3 0.0001
695 CARDIAC FAILURE CONGESTIVE 8 0.0001
696 FALL 33 0.0001
697 PRODUCT PHYSICAL ISSUE 2 0.0001
698 HYPOTHERMIA 1 0.0001
699 FEEDING DISORDER 2 0.0001
700 THERAPY INTERRUPTED 7 0.0001
701 EUPHORIC MOOD 1 0.0001
702 THERAPY CESSATION 5 0.0001
703 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
704 POLLAKIURIA 4 0.0001
705 INJECTION SITE DISCOMFORT 1 0.0001
706 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
707 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
708 BRADYCARDIA 5 0.0001
709 MOOD SWINGS 3 0.0001
710 CONTUSION 9 0.0001
711 ASTHENIA 35 0.0001
712 HYPOACUSIS 4 0.0001
713 DECREASED ACTIVITY 1 0.0001
714 LACTIC ACIDOSIS 3 0.0001
715 BALANCE DISORDER 8 0.0001
716 OSTEONECROSIS 3 0.0001
717 ASPIRATION 1 0.0001
718 BLOOD GLUCOSE FLUCTUATION 1 0.0001
719 EXPIRED PRODUCT ADMINISTERED 3 0.0001
720 LIP SWELLING 3 0.0001
721 FUNGAL INFECTION 3 0.0001
722 TOOTH DISORDER 2 0.0001
723 DRUG INEFFECTIVE 118 0.0001
724 NECK PAIN 5 0.0001
725 GLOSSODYNIA 2 0.0001
726 ORAL PAIN 2 0.0001
727 RASH PAPULAR 2 0.0001
728 PANCREATITIS ACUTE 2 0.0001
729 BLOOD CALCIUM DECREASED 1 0.0001
730 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
731 CHROMATURIA 2 0.0001
732 HEART RATE IRREGULAR 2 0.0001
733 IMPAIRED DRIVING ABILITY 1 0.0001
734 PRODUCT AVAILABILITY ISSUE 2 0.0001
735 HAEMOGLOBIN DECREASED 9 0.0001
736 INJECTION SITE HAEMORRHAGE 7 0.0001
737 INTERNAL HAEMORRHAGE 1 0.0001
738 MEMORY IMPAIRMENT 12 0.0001
739 NEPHROLITHIASIS 4 0.0001
740 MUSCLE TWITCHING 2 0.0001
741 DELIRIUM 3 0.0001
742 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
743 EYELID OEDEMA 1 0.0001
744 HYPERKALAEMIA 3 0.0001
745 WEIGHT INCREASED 19 0.0001
746 PERIPHERAL SWELLING 13 0.0001
747 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
748 BACTERAEMIA 1 0.0001
749 CEREBRAL HAEMORRHAGE 3 0.0001
750 MOBILITY DECREASED 6 0.0001
751 DRUG INTOLERANCE 8 0.0001
752 SUICIDE ATTEMPT 5 0.0001
753 ADRENAL INSUFFICIENCY 1 0.0001
754 VERTIGO 5 0.0001
755 DISCOMFORT 5 0.0001
756 CEREBRAL INFARCTION 2 0.0001
757 LUNG DISORDER 4 0.0001
758 LIVER INJURY 2 0.0001
759 SEPSIS 9 0.0001
760 HEPATIC FUNCTION ABNORMAL 3 0.0001
761 DERMATITIS ALLERGIC 1 0.0001
762 INJECTION SITE PAIN 24 0.0001
763 CHEST DISCOMFORT 8 0.0001
764 HIATUS HERNIA 1 0.0001
765 DIPLOPIA 2 0.0001
766 NERVOUSNESS 4 0.0001
767 HAND DEFORMITY 1 0.0001
768 INCORRECT PRODUCT STORAGE 1 0.0001
769 BEDRIDDEN 1 0.0001
770 IMMUNE SYSTEM DISORDER 1 0.0001
771 DEPRESSED MOOD 4 0.0001
772 PYREXIA 26 0.0001
773 DEHYDRATION 10 0.0001
774 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
775 DIZZINESS 37 0.0001
776 FREQUENT BOWEL MOVEMENTS 2 0.0001
777 THROAT TIGHTNESS 2 0.0001
778 BACK PAIN 17 0.0001
779 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
780 APPLICATION SITE RASH 1 0.0001
781 CARDIAC ARREST 6 0.0001
782 RESPIRATORY DISTRESS 2 0.0001
783 DIVERTICULITIS 2 0.0001
784 PROCEDURAL PAIN 2 0.0001
785 HAEMOPTYSIS 2 0.0001
786 COORDINATION ABNORMAL 1 0.0001
787 APHONIA 1 0.0001
788 CARPAL TUNNEL SYNDROME 1 0.0001
789 BLOOD TEST ABNORMAL 1 0.0001
790 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
791 RENAL FAILURE ACUTE 3 0.0001
792 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
793 PAIN IN JAW 2 0.0001
794 DIALYSIS 1 0.0001
795 CHEST PAIN 13 0.0001
796 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
797 INCORRECT DOSE ADMINISTERED 16 0.0001
798 BRONCHOSPASM 1 0.0001
799 CARDIOGENIC SHOCK 1 0.0001
800 IMPAIRED QUALITY OF LIFE 1 0.0001
801 LETHARGY 4 0.0001
802 BLOOD GLUCOSE INCREASED 13 0.0001
803 INJECTION SITE HAEMATOMA 1 0.0001
804 DYSPNOEA 39 0.0001
805 LIVER FUNCTION TEST ABNORMAL 2 0.0001
806 PALPITATIONS 8 0.0001
807 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
808 PSYCHOTIC DISORDER 2 0.0001
809 COLON CANCER 1 0.0001
810 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
811 HYPOAESTHESIA 10 0.0001
812 BONE LOSS 1 0.0001
813 HALLUCINATION 5 0.0001
814 THERAPEUTIC RESPONSE DECREASED 4 0.0001
815 BLOOD COUNT ABNORMAL 1 0.0001
816 ILL-DEFINED DISORDER 4 0.0001
817 DIABETES MELLITUS 5 0.0001
818 BLOOD PRESSURE INCREASED 10 0.0001
819 SKIN DISCOLOURATION 3 0.0001
820 DEVICE RELATED INFECTION 1 0.0001
821 HYPERSENSITIVITY 12 0.0001
822 SOMNOLENCE 13 0.0001
823 URINARY TRACT INFECTION 11 0.0001
824 NERVOUS SYSTEM DISORDER 2 0.0001
825 PAIN 39 0.0001
826 MYOCARDIAL INFARCTION 11 0.0001
827 PNEUMONIA 20 0.0001
828 AMNESIA 4 0.0001
829 ALOPECIA 12 0.0001
830 SEIZURE 7 0.0001
831 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
832 ARTHRALGIA 25 0.0001
833 VIRAL INFECTION 2 0.0001
834 CHILLS 7 0.0001
835 FACE OEDEMA 1 0.0001
836 CIRCULATORY COLLAPSE 1 0.0001
837 NIGHTMARE 2 0.0001
838 HAEMORRHAGE 6 0.0001
839 DIARRHOEA 37 0.0001
840 WEIGHT DECREASED 16 0.0001
841 MUSCULOSKELETAL PAIN 3 0.0001
842 SPEECH DISORDER 3 0.0001
843 DEPRESSION 13 0.0001
844 AMENORRHOEA 1 0.0001
845 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
846 INSOMNIA 15 0.0001
847 GOUT 1 0.0001
848 GASTROENTERITIS VIRAL 1 0.0001
849 ACCIDENTAL OVERDOSE 2 0.0001
850 MUSCLE SPASMS 10 0.0001
851 ADVERSE EVENT 5 0.0001
852 OROPHARYNGEAL PAIN 5 0.0001
853 DYSARTHRIA 2 0.0001
854 DYSPNOEA EXERTIONAL 2 0.0001
855 BLOOD SODIUM DECREASED 1 0.0001
856 MYALGIA 9 0.0001
857 FLATULENCE 3 0.0001
858 UNEVALUABLE EVENT 4 0.0001
859 MUSCULAR WEAKNESS 6 0.0001
860 FOOT FRACTURE 1 0.0001
861 RENAL FAILURE 7 0.0001
862 BLOOD URINE PRESENT 1 0.0001
863 CHRONIC KIDNEY DISEASE 4 0.0001
864 CONDITION AGGRAVATED 16 0.0001
865 FEELING JITTERY 1 0.0001
866 MALAISE 23 0.0001
867 HERPES ZOSTER 3 0.0001
868 INJECTION SITE SWELLING 4 0.0001
869 HOSPITALISATION 8 0.0001
870 HERNIA 1 0.0001
871 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
872 CHOKING 1 0.0001
873 DYSPEPSIA 5 0.0001
874 INJECTION SITE BRUISING 4 0.0001
875 CARDIAC FAILURE 4 0.0000
876 THROMBOSIS 4 0.0000
877 FULL BLOOD COUNT DECREASED 1 0.0000
878 BONE MARROW FAILURE 1 0.0000
879 ANXIETY 14 0.0000
880 FEELING HOT 3 0.0000
881 SINUSITIS 5 0.0000
882 OSTEOPOROSIS 2 0.0000
883 ILLNESS 5 0.0000
884 INFECTION 7 0.0000
885 RASH 21 0.0000
886 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
887 ROAD TRAFFIC ACCIDENT 2 0.0000
888 URTICARIA 8 0.0000
889 DERMATITIS 1 0.0000
890 RENAL IMPAIRMENT 4 0.0000
891 HALLUCINATION, VISUAL 1 0.0000
892 RECTAL HAEMORRHAGE 2 0.0000
893 SWELLING FACE 3 0.0000
894 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
895 LIVER DISORDER 2 0.0000
896 COLITIS ULCERATIVE 2 0.0000
897 PRURITUS 17 0.0000
898 ABDOMINAL PAIN UPPER 9 0.0000
899 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
900 BREAST CANCER 4 0.0000
901 BLOOD CHOLESTEROL INCREASED 2 0.0000
902 CARDIAC DISORDER 4 0.0000
903 ARRHYTHMIA 2 0.0000
904 COMA 2 0.0000
905 PRODUCTIVE COUGH 2 0.0000
906 RASH ERYTHEMATOUS 2 0.0000
907 GAIT DISTURBANCE 8 0.0000
908 HEPATIC CANCER 1 0.0000
909 TOXICITY TO VARIOUS AGENTS 7 0.0000
910 FIBROMYALGIA 1 0.0000
911 BRONCHITIS 3 0.0000
912 DYSGEUSIA 3 0.0000
913 AGGRESSION 2 0.0000
914 COVID-19 7 0.0000
915 CELLULITIS 2 0.0000
916 HAEMATEMESIS 1 0.0000
917 FLUSHING 4 0.0000
918 FLUID RETENTION 2 0.0000
919 COUGH 11 0.0000
920 LOSS OF CONSCIOUSNESS 5 0.0000
921 ERYTHEMA 8 0.0000
922 ANAPHYLACTIC SHOCK 1 0.0000
923 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
924 DEAFNESS 1 0.0000
925 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
926 ARTHRITIS 3 0.0000
927 PARAESTHESIA 6 0.0000
928 ANHEDONIA 1 0.0000
929 FEAR 1 0.0000
930 DISTURBANCE IN ATTENTION 2 0.0000
931 HAEMATOCHEZIA 2 0.0000
932 TREMOR 6 0.0000
933 DEATH 31 0.0000
934 FEELING COLD 1 0.0000
935 SKIN EXFOLIATION 3 0.0000
936 INTENTIONAL DOSE OMISSION 1 0.0000
937 HYPERSOMNIA 1 0.0000
938 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
939 DEVICE ISSUE 3 0.0000
940 ADVERSE DRUG REACTION 3 0.0000
941 FEELING ABNORMAL 8 0.0000
942 IRRITABILITY 2 0.0000
943 BLOOD POTASSIUM DECREASED 1 0.0000
944 APHASIA 1 0.0000
945 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
946 STOMATITIS 2 0.0000
947 DRUG ADMINISTRATION ERROR 1 0.0000
948 EMOTIONAL DISORDER 1 0.0000
949 SWELLING 3 0.0000
950 IMPAIRED HEALING 1 0.0000
951 ABDOMINAL DISCOMFORT 5 0.0000
952 SLEEP DISORDER 2 0.0000
953 SKIN BURNING SENSATION 2 0.0000
954 NO ADVERSE EVENT 5 0.0000
955 DRUG EFFECT INCOMPLETE 1 0.0000
956 AGITATION 2 0.0000
957 PRODUCT DOSE OMISSION ISSUE 8 0.0000
958 EYE SWELLING 1 0.0000
959 EPISTAXIS 2 0.0000
960 ACNE 2 0.0000
961 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
962 ABNORMAL BEHAVIOUR 1 0.0000
963 DISORIENTATION 1 0.0000
964 BLINDNESS 1 0.0000
965 CEREBROVASCULAR ACCIDENT 4 0.0000
966 OVERDOSE 5 0.0000
967 PSORIASIS 3 0.0000
968 MUSCULOSKELETAL STIFFNESS 2 0.0000
969 COGNITIVE DISORDER 1 0.0000
970 DYSPHAGIA 2 0.0000
971 DRY EYE 1 0.0000
972 DRUG DOSE OMISSION 3 0.0000
973 ANAPHYLACTIC REACTION 1 0.0000
974 BLISTER 1 0.0000
975 ASTHMA 2 0.0000
976 CONVULSION 1 0.0000
977 DYSPHONIA 1 0.0000
978 JOINT SWELLING 2 0.0000
979 EMOTIONAL DISTRESS 2 0.0000
980 VISUAL IMPAIRMENT 2 0.0000
981 DEVICE DIFFICULT TO USE 1 0.0000
982 DRY SKIN 2 0.0000
983 BURNING SENSATION 1 0.0000
984 INFLUENZA LIKE ILLNESS 1 0.0000
985 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
986 DRUG WITHDRAWAL SYNDROME 1 0.0000
987 GASTROINTESTINAL DISORDER 1 0.0000
988 NASOPHARYNGITIS 2 0.0000
989 HEART RATE INCREASED 1 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
991 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
992 INFLUENZA 1 0.0000